Cognitive and neurobiologic markers of early Alzheimer disease.

Recent studies indicate that impairments in two cognitive domains characterize the cognitive abnormalities that appear earliest in the course of Alzheimer disease (AD). These cognitive domains pertain to memory and executive function ability; in particular, memory test scores reflecting the difference between immediate and delayed recall and tasks that assess cognitive flexibility (e.g., set-shifting). Preliminary data indicate that tasks of this nature, along with specific genetic information (i.e., APOE-4 status), are important in identifying which individuals with recent cognitive changes (considered to have "questionable" disease) will progress to the point where they meet criteria for AD over time. When this cognitive and genetic information is combined with neuroimaging measures targeted at the brain regions demonstrating pathology early in AD, it may serve as specific and accurate prognostic markers of AD.

[1]  S Lehéricy,et al.  Amygdalohippocampal MR volume measurements in the early stages of Alzheimer disease. , 1994, AJNR. American journal of neuroradiology.

[2]  R D Hill,et al.  Very mild senile dementia of the Alzheimer type. II. Psychometric test performance. , 1989, Archives of neurology.

[3]  O Nalcioglu,et al.  Quantification of magnetic resonance scans for hippocampal and parahippocampal atrophy in Alzheimer's disease , 1991, Neurology.

[4]  D. Salmon,et al.  Physical basis of cognitive alterations in alzheimer's disease: Synapse loss is the major correlate of cognitive impairment , 1991, Annals of neurology.

[5]  D. Rosene.  Comparing age-related changes in the basal forebrain and hippocampus of the rhesus monkey , 1993, Neurobiology of Aging.

[6]  J. Whisnant.  The role of the neurologist in the decline of stroke. , 1983, Annals of neurology.

[7]  M. Albert,et al.  Temporal lobe regions on magnetic resonance imaging identify patients with early Alzheimer's disease. , 1993, Archives of neurology.

[8]  J T Becker,et al.  Working memory and secondary memory deficits in Alzheimer's disease. , 1988, Journal of clinical and experimental neuropsychology.

[9]  D. Stuss,et al.  Memory Scanning and Structured Learning in Alzheimer's Disease and Parkinson' Disease , 1990, Canadian Journal on Aging / La Revue canadienne du vieillissement.

[10]  A. Kaszniak,et al.  Primary memory and secondary memory in dementia of the Alzheimer type. , 1983, Journal of clinical neuropsychology.

[11]  M. Albert,et al.  Use of computerized CT analysis to discriminate between Alzheimer patients and normal control subjects. , 1988, AJNR. American journal of neuroradiology.

[12]  E. Masliah,et al.  Quantitative synaptic alterations in the human neocortex during normal aging , 1993, Neurology.

[13]  M. Albert,et al.  Executive function deficits in mild Alzheimer's disease. , 1995 .

[14]  G. V. Van Hoesen,et al.  Perforant pathway changes and the memory impairment of Alzheimer's disease , 1986, Annals of neurology.

[15]  D. Pollen,et al.  Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease , 1995, Nature.

[16]  S. Harkins,et al.  Rate of forgetting in mild Alzheimer's-type dementia , 1988, Brain and Cognition.

[17]  E. Tangalos,et al.  Memory function in normal aging , 1992, Neurology.

[18]  M J de Leon,et al.  CT diagnostic features of Alzheimer disease: importance of the choroidal/hippocampal fissure complex. , 1990, AJNR. American journal of neuroradiology.

[19]  Wayne A. Wickelgren,et al.  Age and storage dynamics in continuous recognition memory. , 1975 .

[20]  T. Arendt,et al.  Neuronal loss in different parts of the nucleus basalis is related to neuritic plaque formation in cortical target areas in alzheimer's disease , 1985, Neuroscience.

[21]  M. Pericak-Vance,et al.  Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease , 1991, Nature.

[22]  J. Troncoso,et al.  Differences in the pattern of hippocampal neuronal loss in normal ageing and Alzheimer's disease , 1994, The Lancet.

[23]  Seth J. Ramus,et al.  Severity of memory impairment in monkeys as a function of locus and extent of damage within the medial temporal lobe memory system , 1994, Hippocampus.

[24]  D. Amaral.  Morphological analyses of the brains of behaviorally characterized aged nonhuman primates , 1993, Neurobiology of Aging.

[25]  J. Morris,et al.  Profound Loss of Layer II Entorhinal Cortex Neurons Occurs in Very Mild Alzheimer’s Disease , 1996, The Journal of Neuroscience.

[26]  G. Schellenberg,et al.  Candidate gene for the chromosome 1 familial Alzheimer's disease locus , 1995, Science.

[27]  A. D. Roses,et al.  Association of apolipoprotein E allele €4 with late-onset familial and sporadic Alzheimer’s disease , 2006 .

[28]  R. Reitan.  Validity of the Trail Making Test as an Indicator of Organic Brain Damage , 1958 .

[29]  J. Haxby,et al.  Clinical history, brain metabolism, and neuropsychological function in Alzheimer's disease , 1985, Annals of neurology.

[30]  H. Soininen,et al.  The interuncal distance in Alzheimer disease and age-associated memory impairment. , 1995, AJNR. American journal of neuroradiology.

[31]  M. Albert,et al.  Differential patterns of memory loss among patients with Alzheimer's disease, Huntington's disease, and alcoholic Korsakoff's syndrome. , 1986, Archives of neurology.

[32]  F. Craik.  Age Differences in Recognition Memory , 1971 .

[33]  B. Milner,et al.  Deficits on subject-ordered tasks after frontal- and temporal-lobe lesions in man , 1982, Neuropsychologia.

[34]  S. DeKosky,et al.  Synapse loss in frontal cortex biopsies in Alzheimer's disease: Correlation with cognitive severity , 1990, Annals of neurology.

[35]  A. Baddeley,et al.  Primary and working memory functioning in Alzheimer-type dementia. , 1988, Journal of clinical and experimental neuropsychology.

[36]  N Butters,et al.  Detection and staging of dementia in Alzheimer's disease. Use of the neuropsychological measures developed for the Consortium to Establish a Registry for Alzheimer's Disease. , 1992, Archives of neurology.

[37]  M. Albert,et al.  Cognitive differences between patients with progressive supranuclear palsy and Alzheimer's disease. , 1989, Journal of clinical and experimental neuropsychology.

[38]  J. Haxby,et al.  Heterogeneous anterior‐posterior metabolic patterns in dementia of the Alzheimer type , 1988, Neurology.

[39]  T. Robbins,et al.  Sparing of attentional relative to mnemonic function in a subgroup of patients with dementia of the Alzheimer type , 1990, Neuropsychologia.

[40]  A. Levey,et al.  Cholinergic innervation of cortex by the basal forebrain: Cytochemistry and cortical connections of the septal area, diagonal band nuclei, nucleus basalis (Substantia innominata), and hypothalamus in the rhesus monkey , 1983, The Journal of comparative neurology.

[41]  R. Kikinis,et al.  Comparative analysis of computed tomographic and magnetic resonance imaging scans in Alzheimer patients and controls. , 1992, Archives of neurology.

[42]  D. Mann,et al.  A quantitative morphometric analysis of the neuronal and synaptic content of the frontal and temporal cortex in patients with Alzheimer's disease , 1987, Journal of the Neurological Sciences.

[43]  Luigi Mansi,et al.  Regional cortical dysfunction in Alzheimer's disease as determined by positron emission tomography , 1984, Annals of neurology.

[44]  G. V. Van Hoesen,et al.  Alzheimer's disease: cell-specific pathology isolates the hippocampal formation. , 1984, Science.

[45]  W. Jagust,et al.  Quantitative NMR measurements of hippocampal atrophy in Alzheimer's disease , 1988, Magnetic resonance in medicine.

[46]  M J Campbell,et al.  Laminar and regional distributions of neurofibrillary tangles and neuritic plaques in Alzheimer's disease: a quantitative study of visual and auditory cortices , 1987, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[47]  D. Price,et al.  Synapse loss in the temporal lobe in Alzheimer's disease , 1993, Annals of neurology.